Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN, Cochrane DR, Richer JK. Howe EN, et al. Among authors: cochrane dr. Breast Cancer Res. 2011 Apr 18;13(2):R45. doi: 10.1186/bcr2867. Breast Cancer Res. 2011. PMID: 21501518 Free PMC article.
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK. Cochrane DR, et al. Mol Cancer Ther. 2009 May;8(5):1055-66. doi: 10.1158/1535-7163.MCT-08-1046. Epub 2009 May 12. Mol Cancer Ther. 2009. PMID: 19435871 Free PMC article.
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.
Cochrane DR, Howe EN, Spoelstra NS, Richer JK. Cochrane DR, et al. J Oncol. 2010;2010:821717. doi: 10.1155/2010/821717. Epub 2009 Dec 15. J Oncol. 2010. PMID: 20049172 Free PMC article.
Steroid receptors and microRNAs: relationships revealed.
Cochrane DR, Cittelly DM, Richer JK. Cochrane DR, et al. Steroids. 2011 Jan;76(1-2):1-10. doi: 10.1016/j.steroids.2010.11.003. Epub 2010 Nov 18. Steroids. 2011. PMID: 21093468 Review.
MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.
Cochrane DR, Cittelly DM, Howe EN, Spoelstra NS, McKinsey EL, LaPara K, Elias A, Yee D, Richer JK. Cochrane DR, et al. Horm Cancer. 2010 Dec;1(6):306-19. doi: 10.1007/s12672-010-0043-5. Horm Cancer. 2010. PMID: 21761362 Free PMC article.
The role of miRNAs in progesterone action.
Cochrane DR, Spoelstra NS, Richer JK. Cochrane DR, et al. Mol Cell Endocrinol. 2012 Jun 24;357(1-2):50-9. doi: 10.1016/j.mce.2011.09.022. Epub 2011 Sep 17. Mol Cell Endocrinol. 2012. PMID: 21952083 Review.
Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.
Cochrane DR, Jacobsen BM, Connaghan KD, Howe EN, Bain DL, Richer JK. Cochrane DR, et al. Mol Cell Endocrinol. 2012 May 15;355(1):15-24. doi: 10.1016/j.mce.2011.12.020. Epub 2012 Jan 18. Mol Cell Endocrinol. 2012. PMID: 22330642 Free PMC article.
The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity.
Howe EN, Cochrane DR, Richer JK. Howe EN, et al. Among authors: cochrane dr. J Mammary Gland Biol Neoplasia. 2012 Mar;17(1):65-77. doi: 10.1007/s10911-012-9244-6. Epub 2012 Feb 17. J Mammary Gland Biol Neoplasia. 2012. PMID: 22350980 Free PMC article. Review.
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
Cittelly DM, Dimitrova I, Howe EN, Cochrane DR, Jean A, Spoelstra NS, Post MD, Lu X, Broaddus RR, Spillman MA, Richer JK. Cittelly DM, et al. Among authors: cochrane dr. Mol Cancer Ther. 2012 Dec;11(12):2556-65. doi: 10.1158/1535-7163.MCT-12-0463. Epub 2012 Oct 16. Mol Cancer Ther. 2012. PMID: 23074172 Free PMC article.
miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
Howe EN, Cochrane DR, Cittelly DM, Richer JK. Howe EN, et al. Among authors: cochrane dr. PLoS One. 2012;7(11):e49987. doi: 10.1371/journal.pone.0049987. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185507 Free PMC article.
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback